Outcome of allogeneic stem cell transplantation in patients with chronic myeloid leukaemia treated with second generation tyrosine kinases inhibitors after imatinib failure

被引：0
|
作者：
Palandri, F.
Breccia, M. [1 ]
Iori, A. P. [1 ]
Bonifazi, F.
Latagliata, R. [1 ]
Colaci, E.
Torelli, G. F. [1 ]
Castagnetti, F.
Valle, V. [1 ]
Usai, S. [1 ]
Martinelli, G.
Dell'Agnola, C. [2 ]
Cingarlini, S. [2 ]
Rosti, G.
Baccarani, M.
Alimena, G. [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
[2] Policlin GB Rossi, Verona, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [1] The impact of second generation tyrosine kinase inhibitors on the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia
    Latif, A.
    Parker, A.
    McQuaker, G.
    Clark, A.
    Copland, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 23 - 24
  • [2] Use of second generation tyrosine kinase inhibitors prior to allogeneic stem cell transplantation in chronic myeloid leukaemia
    Olavarria, E.
    Schleuning, M.
    Chalandon, Y.
    Onida, F.
    Radujkovic, A.
    Robin, M.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S35 - S36
  • [3] Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib
    Breccia, Massimo
    Palandri, Francesca
    Iori, Anna Paola
    Colaci, Elisabetta
    Latagliata, Roberto
    Castagnetti, Fausto
    Torelli, Giovanni Fernando
    Usai, Sara
    Valle, Veronica
    Martinelli, Giovanni
    Rosti, Gianantonio
    Foa, Robin
    Baccarani, Michele
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2010, 34 (02) : 143 - 147
  • [4] Allogeneic haemotopoietic stem cell transplantation outcomes in imatinib-treated chronic myeloid leukaemia patients
    Ahn, H. K.
    Jung, C. W.
    Kim, K.
    Jang, J. H.
    Kim, D. H.
    Yoon, S. S.
    Kim, I. H.
    Sohn, S. K.
    Moon, J. H.
    Lee, J. H.
    Lee, K. H.
    Won, J. H.
    Lee, N. S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S244 - S244
  • [5] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia
    Perz, JB
    Sanz, J
    Ghorashian, S
    Chaidos, A
    Kaeda, J
    Szydlo, RM
    Marin, DC
    Olavarria, E
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 : S227 - S227
  • [6] Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia
    Koldehoff, M
    Elmaagacli, AH
    Steckel, NK
    Hlinka, M
    Ditschkowski, M
    Trenschel, R
    Peceny, R
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [7] Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure
    Jabbour, Elias
    Kantarjian, Hagop
    O'Brien, Susan
    Shan, Jenny
    Garcia-Manero, Guillermo
    Wierda, William
    Ravandi, Farhad
    Borthakur, Gautam
    Rios, Mary Beth
    Cortes, Jorge
    BLOOD, 2011, 117 (06) : 1822 - 1827
  • [8] Favorable Outcome of Chronic Myeloid Leukemia Patients Treated with Imatinib Vs Early Allogeneic Stem Cell Transplantation
    Hasford, Joerg
    Lauseker, Michael
    Gathmann, Insa
    Pfirrmann, Markus
    Larson, Richard A.
    Guilhot, Francois
    O'Brien, Stephen G.
    Druker, Brian J.
    Hchlmann, Ruediger
    Hochhaus, Andreas
    BLOOD, 2008, 112 (11) : 739 - 740
  • [9] Second-Generation Tyrosine Kinase Inhibitors Combined With Stem Cell Transplantation in Patients With Imatinib-Refractory Chronic Myeloid Leukemia
    Zhao, Yanmin
    Luo, Yi
    Shi, Jimin
    Cai, Zhen
    Huang, He
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (06): : 439 - 445
  • [10] Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemia
    Koldehoff, M.
    Elmaagacli, A. H.
    Ditschkowski, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S428 - S428
12345